Discontinuation report ZOFRAN

Last updated on 2021-05-05 History
Report ID 123894
Drug Identification Number 02213745
Brand name ZOFRAN
Common or Proper name ZOFRAN INJ 4MG AMPS 2ML 5'S
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ONDANSETRON
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 2ML X 5'S
ATC code A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2021-03-31
Actual discontinuation date 2021-04-19
Remaining supply date 2023-02-28
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2021-05-05 French Compare
v9 2021-05-05 English Compare
v8 2021-03-09 French Compare
v7 2021-03-09 English Compare
v6 2020-11-06 French Compare
v5 2020-11-06 English Compare
v4 2020-11-06 French Compare
v3 2020-11-06 English Compare
v2 2020-09-09 French Compare
v1 2020-09-09 English Compare

Showing 1 to 10 of 10